Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Dr. DivyajotSandhu, a highly skilled neurologist with advanced training in vascular neurology and endovascular surgical neuroradiology, brings his extensive clinical and research expertise to Omexa Biologics as a Board Advisor. With his leadership roles at Sanford-USD Medical Center and the University of South Dakota, Dr. Sandhu provide
Dr. DivyajotSandhu, a highly skilled neurologist with advanced training in vascular neurology and endovascular surgical neuroradiology, brings his extensive clinical and research expertise to Omexa Biologics as a Board Advisor. With his leadership roles at Sanford-USD Medical Center and the University of South Dakota, Dr. Sandhu provides invaluable insights into advancing Omexa’s mission of reducing biologics costs and improving patient outcomes. His expertise in complex vascular treatments and commitment to cutting-edge research aligns with Omexa’s focus on innovation in healthcare solutions.
Dr. Navdeep Sangha, MD, is a highly skilled and dedicated neurologist specializing in vascular neurology. He serves as an Attending Physician in Vascular Neurology at Kaiser Permanente Los Angeles Medical Center and is the Regional Medical Director for Stroke and Telestrokeat Kaiser Permanente Southern California. Dr. Sangha is active
Dr. Navdeep Sangha, MD, is a highly skilled and dedicated neurologist specializing in vascular neurology. He serves as an Attending Physician in Vascular Neurology at Kaiser Permanente Los Angeles Medical Center and is the Regional Medical Director for Stroke and Telestrokeat Kaiser Permanente Southern California. Dr. Sangha is actively involved in academic committees, educational initiatives, and editorial responsibilities for organizations like the International Stroke Conference and the American Academy of Neurology. At Omexa, he provides clinical trial guidance for various molecules.
Dr. Verma is an ophthalmologist and professor of ophthalmology and preventive medicine. In 2014, he was named director of the USC Eye Institute and chairman of the Department of Ophthalmology for Keck School of Medicine of USC. In October 2018, Varma became the founding director of the Southern California Eyecare and Vision Research Ins
Dr. Verma is an ophthalmologist and professor of ophthalmology and preventive medicine. In 2014, he was named director of the USC Eye Institute and chairman of the Department of Ophthalmology for Keck School of Medicine of USC. In October 2018, Varma became the founding director of the Southern California Eyecare and Vision Research Institute. Since 2021, Dr Varma also serves as Chief Medical Officer of Hollywood Presbyterian Medical Center. At Omexa, Dr. Varma provides business development and clinical trial guidance.
Dr. Nathan is an Internal Medicine Specialist and the President of Northwestern Medicine Huntley Hospital since 2018. Prior to that he was the President of Huntley Hospital and Clinical Effectiveness. Over the past 23 years, Dr. Kumar has held various roles as a Medical Executive and as faculty. At Omexa, he provides market insights and guidance to US healthcare systems.
Copyright © 2024 Ayur Inc dba Omexa Biologics - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.